Predictors of family-based treatment for adolescent eating disorders: Do family or diagnostic factors matter?


Journal

The International journal of eating disorders
ISSN: 1098-108X
Titre abrégé: Int J Eat Disord
Pays: United States
ID NLM: 8111226

Informations de publication

Date de publication:
02 2023
Historique:
revised: 18 11 2022
received: 22 09 2022
accepted: 18 11 2022
pmc-release: 01 02 2024
pubmed: 2 12 2022
medline: 3 2 2023
entrez: 1 12 2022
Statut: ppublish

Résumé

Misconceptions around which patients will and will not benefit from family-based treatment (FBT) for adolescent eating disorders (EDs) limit referrals and access to this treatment modality. The present study explored whether common demographic and clinical factors that may prevent referral to FBT predict treatment outcomes in adolescent anorexia nervosa (AN) and bulimia nervosa (BN). The following predictors of treatment outcomes were assessed: baseline family and diagnostic factors (socioeconomic status, comorbidity, illness duration, parent feelings of self-efficacy, family status, prior treatment, sex and prior hospitalizations) in a combined sample of adolescents receiving FBT compared to those randomized to other treatment conditions, across six clinical trials in the United States and Canada (total n = 724, ages 12-18, 90% female across both diagnoses). AN and BN samples were examined separately. Any prior ED treatment emerged as the only predictor of outcome in AN and BN, such that having no prior treatment predicted better outcomes in FBT for AN, and in both FBT and other treatment modalities for BN. No other sociodemographic or clinical variables predicted outcomes for AN or BN in FBT or in other evidence-based treatment modalities. The findings of this exploratory analysis suggest that commonly assumed factors do not predict outcome in FBT. Specifically socioeconomic and demographic factors or clinical variability in families seeking treatment do not predict treatment outcomes in FBT, or other evidence-based treatment modalities, with the exception of prior treatment. Providers should consider referring to FBT even when these factors are present. This manuscript reports that commonly assumed family, sociodemographic and diagnostic factors do not predict outcome in FBT or other evidence-based treatment modalities, with the exception of prior treatment. This data may be helpful for providers when considering referrals to FBT in the context of variability in these variables.

Identifiants

pubmed: 36454189
doi: 10.1002/eat.23867
pmc: PMC9898138
mid: NIHMS1852260
doi:

Types de publication

Randomized Controlled Trial Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

384-393

Subventions

Organisme : NIMH NIH HHS
ID : K23 MH126201
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH070620
Pays : United States
Organisme : NINDS NIH HHS
ID : R25 NS117367
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH082706
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH110538
Pays : United States
Organisme : NIMH NIH HHS
ID : R34 MH093768
Pays : United States
Organisme : NIMH NIH HHS
ID : R34 MH093493
Pays : United States
Organisme : NIMH NIH HHS
ID : U01 MH076290
Pays : United States
Organisme : NIMH NIH HHS
ID : R34 MH101281
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH079979
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH070621
Pays : United States

Informations de copyright

© 2022 Wiley Periodicals LLC.

Références

Eur Eat Disord Rev. 2018 Jan;26(1):62-68
pubmed: 29152825
Int J Eat Disord. 2006 Jan;39(1):27-34
pubmed: 16231336
J Am Acad Child Adolesc Psychiatry. 2005 Jul;44(7):632-9
pubmed: 15968231
J Am Acad Child Adolesc Psychiatry. 2015 Nov;54(11):886-94.e2
pubmed: 26506579
JAMA. 2022 Mar 15;327(11):1061-1067
pubmed: 35289876
Front Psychiatry. 2020 Feb 12;11:41
pubmed: 32116856
Am J Psychiatry. 2006 Jul;163(7 Suppl):4-54
pubmed: 16925191
Turk Psikiyatri Derg. 2019 Spring;30(1):42-50
pubmed: 31170306
Arch Gen Psychiatry. 2010 Oct;67(10):1025-32
pubmed: 20921118
Int J Eat Disord. 2006 Apr;39(3):175-83
pubmed: 16485268
Psychother Res. 2013;23(3):333-43
pubmed: 23088433
JAMA Psychiatry. 2014 Nov;71(11):1279-86
pubmed: 25250660
J Clin Child Adolesc Psychol. 2022 Aug 11;:1-12
pubmed: 35950931
Curr Psychiatry Rep. 2016 Apr;18(4):36
pubmed: 26893234
J Eat Disord. 2018 Dec 3;6:44
pubmed: 30603086
Psychol Med. 2019 Mar;49(4):697-698
pubmed: 30514406
Pediatrics. 2012 Feb;129(2):e438-46
pubmed: 22218841
J Am Acad Child Adolesc Psychiatry. 1997 Jul;36(7):980-8
pubmed: 9204677
Contemp Clin Trials. 2022 Sep;120:106889
pubmed: 35998767
J Eat Disord. 2020 Feb 01;8:4
pubmed: 32021688
Int J Eat Disord. 2020 Aug;53(8):1204-1208
pubmed: 31469436
Int J Eat Disord. 2019 Jul;52(7):759-776
pubmed: 31169332
Int J Eat Disord. 2013 Mar;46(2):177-88
pubmed: 22911878
JAMA. 2006 Sep 13;296(10):1286-9
pubmed: 16968853
J Am Acad Child Adolesc Psychiatry. 2006 Jun;45(6):666-672
pubmed: 16721316
Behav Res Ther. 2015 Oct;73:90-5
pubmed: 26276704
J Clin Med. 2019 Jan 29;8(2):
pubmed: 30700054
Eur Eat Disord Rev. 2020 Jul;28(4):445-453
pubmed: 32130757
Int J Eat Disord. 2019 Apr;52(4):481-487
pubmed: 30520532

Auteurs

Nandini Datta (N)

Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California, USA.

Kelsey Hagan (K)

Department of Psychiatry, New York State Psychiatric Institute, Columbia University Irving Medical Center, New York, New York, USA.

Cara Bohon (C)

Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California, USA.
Equip Health, Inc., Carlsbad, California, USA.

May Stern (M)

Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California, USA.

Bohye Kim (B)

Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California, USA.

Brittany E Matheson (BE)

Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California, USA.

Sasha Gorrell (S)

Department of Psychiatry & Behavioral Sciences, University of California, San Francisco, San Francisco, California, USA.

Daniel Le Grange (D)

Department of Psychiatry & Behavioral Sciences, University of California, San Francisco, San Francisco, California, USA.
Department of Psychiatry & Behavioral Neuroscience, The University of Chicago, Chicago, Illinois (Emeritus), USA.

James D Lock (JD)

Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH